NiaHealth
Dan Pawliw is an accomplished professional with extensive experience in the healthcare and investment sectors. Currently serving as an Advisor at NiaHealth and as an Investor and Advisor at Healthkind since early 2023, Dan previously held the position of Managing Director for TELUS Health M&A from 2020 to 2022, overseeing mergers and acquisitions. As the Co-Founder and CEO of Akira Health from 2016 to 2021, Dan played a pivotal role in revolutionizing healthcare delivery in Canada. Earlier career highlights include serving as Chief Commercial Officer at Medcan, focusing on corporate development and management across diverse health-related fields, and undertaking investment roles at CMGI @Ventures, JPMorgan Chase, and Goldman Sachs. Dan holds an MBA from Northwestern University's Kellogg School of Management and a degree from Queen's University.
This person is not in any teams
NiaHealth
1 followers
In recent years, led by thought leaders such as Peter Attia, Andrew Huberman, Mark Hyman, and David Sinclair, among others, a movement has accelerated around proactive health. NiaHealth aspires to translate the core tenets of this movement into practice by becoming the world’s leading, virtual-first, proactive health partner. We currently offer comprehensive blood testing, personalized health analytics and tailored recommendations to address the most pressing threats to your healthspan and longevity. We will soon be incorporating other diagnostics such as VO2 Max, DEXA scans, genetic testing, among others.